https://www.selleckchem.com/pr....oducts/740-y-p-pdgfr
Patients who had myopia, astigmatism, glaucoma, cataract, etc. prior to their KD diagnosis were excluded. The age range was 0 to 6 years old. According to the cumulative curves, our results demonstrated that the myopic incidence in the IVIG group was significantly lower than the aspirin group (hazard ratio 0.59, 95% confidence intervals 0.36~0.96, p = 0.02). Treatment with IVIG for KD patients may have benefit for myopia control. Conclusion Compared to aspirin, IVIG may decrease the myopic risk in KD patients. However, it n
Like
Comment
Share
